HIV protease mutations leading to reduced inhibitor susceptibility.
Korant
B
B
Molecular Biology Division, DuPont Merck Pharmaceutical Co, Glenolden, Pennsylvania 19036, USA.
Lu
Z
Z
Strack
P
P
Rizzo
C
C
D000596:Amino Acids / Q000032:analysis; D016333:HIV Protease / Q000737:chemistry / Q000187:drug effects / Q000235:genetics*; D017320:HIV Protease Inhibitors / Q000737:chemistry / Q000494:pharmacology*; D006801:Humans; D008156:Luciferases / Q000737:chemistry; D015394:Molecular Structure; D009154:Mutation; D013329:Structure-Activity Relationship; D014508:Urea / Q000737:chemistry*
D000596:Amino Acids; D017320:HIV Protease Inhibitors; D014508:Urea; D008156:Luciferases; D016333:HIV Protease